Phase 2 Clinical Trials

Garetosmab Phase 2 Results Expected

Trevogrumab-Part A Phase 2 Results Expected

coformulation pembrolizumab/quavonlimab Phase 2 Results Expected

Psilocybin therapy Phase 2 Results Expected

Multivalent Pneumococcal Vaccine - Formulation 1 Phase 2 Results Expected

AZD6234 Phase 2 Results Expected

AZD9550 Phase 2 Results Expected

AZD6234 Phase 2 Results Expected

mRNA-1345 Phase 2 Results Expected

Pandemic flu H5 HA mRNA SD2 vaccine Phase 2 Results Expected

rF1V-1018 Phase 2 Results Expected

VX-264 Phase 2 Results Expected

DR10624 Injection Phase 2 Results Expected

Lenalidomide Phase 2 Results Expected

Low-dose experimental vaccine Phase 2 Results Expected

Lenvatinib Phase 2 Results Expected

MK-4830 Phase 2 Results Expected

APG-115 Phase 2 Results Expected

Belzutifan Phase 2 Results Expected

Pembrolizumab/Quavonlimab Phase 2 Results Expected

Vibostolimab/Pembrolizumab Phase 2 Results Expected

Tominersen Phase 2 Results Expected

disitamab vedotin Phase 2 Results Expected

Favezelimab/Pembrolizumab Phase 2 Results Expected

BMS-986158 Phase 2 Results Expected

IV Decitabine Phase 2 Results Expected

APG-2575 Phase 2 Results Expected

ARCT-810 Phase 2 Results Expected

Cetuximab Phase 2 Results Expected

REGN9933 Phase 2 Results Expected

REGN7508 Phase 2 Results Expected

CD40 agonist mitazalimab in combination with chemotherapy Phase 2 Results Expected

Adagrasib oral dose of 400 mg twice daily tablets Phase 2 Results Expected

CID-103 Phase 2 Results Expected

Placebo Phase 2 Results Expected

INE963 Phase 2 Results Expected

KAE609 (Cipargamin) Phase 2 Results Expected

TAK-755 Phase 2 Results Expected

vilastobart (XTX101) Phase 2 Results Expected

AZD7798 Phase 2 Results Expected

Epcoritamab Phase 2 Results Expected

4D-310 Phase 2 Results Expected

SPY001 Phase 2 Results Expected

Tirzepatide Phase 2 Results Expected

LY3848575 Phase 2 Results Expected

ADI-270 Phase 2 Results Expected

ARO-DIMERPA Phase 2 Results Expected

Oral hexavalent reassortant rotavirus attenuated live vaccine Phase 2 Results Expected

EDG-7500 Phase 2 Results Expected

avutometinib and sotorasib Phase 2 Results Expected

Ivaltinostat Phase 2 Results Expected

0.5 mg epinephrine Phase 2 Results Expected

4D-125 IVT Injection Phase 2 Results Expected

B10 L-BPA Injection Phase 2 Results Expected

bempikibart (ADX-914) Phase 2 Results Expected

SHR- A1811 Phase 2 Results Expected

barzolvolimab Phase 2 Results Expected

BL-M07D1 Phase 2 Results Expected

LY3841136 Phase 2 Results Expected

STSA-1301 subcutaneous injection Phase 2 Results Expected

ACI-24.060 at Dose A Phase 2 Results Expected

TCMCB07 Phase 2 Results Expected

ARQ-151 cream 0.05% Phase 2 Results Expected

Naldemedine Phase 2 Results Expected

9-ING-41 Phase 2 Results Expected

Low Dose PRT042 nasal spray Phase 2 Results Expected

Pegtibatinase Phase 2 Results Expected

ABD-3001 Phase 2 Results Expected

LY3305677 Phase 2 Results Expected

ALKS 2680 Phase 2 Results Expected

Placebo Phase 2 Results Expected

HRS-5041 tablets Phase 2 Results Expected

GRF312 5% Phase 2 Results Expected